Using the MR-Base platform to investigate risk factors and drug targets for thousands of phenotypes. (2019)
Attributed to:
Reproductive and cardio-metabolic health
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.12688/wellcomeopenres.15334.2
PubMed Identifier: 31448343
Publication URI: http://europepmc.org/abstract/MED/31448343
Type: Journal Article/Review
Volume: 4
Parent Publication: Wellcome open research
ISSN: 2398-502X